5-methoxy-2-methyl-1H-indole-3-propanoic acid methyl ester | 163735-09-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-methoxy-2-methyl-1H-indole-3-propanoic acid methyl ester
• 英文别名: methyl 3-(5-methoxy-2-methyl-1H-indol-3-yl)propanoate
• CAS: 163735-09-9
• 化学式: C₁₄H₁₇NO₃
• 分子量: 247.294
• InChiKey: GAQUCNBIGWWQMF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  51.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-methoxy-2-methyl-1H-indole-3-propanoic acid methyl ester 在 lithium aluminium tetrahydride 、 sodium hydride 、 caesium carbonate 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 1-Benzyl-3-[3-[3-fluoro-5-(4-methoxyoxan-4-yl)phenoxy]propyl]-5-methoxy-2-methylindole
  参考文献：
  名称：

  Indole derivatives as potent inhibitors of 5-lipoxygenase: Design, synthesis, biological evaluation, and molecular modeling

  摘要：

  A series of novel indole derivatives was designed, synthesized and evaluated by cell-based assays for their inhibitory activities against 5-LOX in rat peritoneal leukocytes. Most of them (30 out of 35) showed an inhibitory potency higher than the initial screening hit 1a (IC50 = 74 mu M). Selected compounds for concentration-response studies showed prominent inhibitory activities with IC50 values ranging from 0.74 mu M to 3.17 mu M. Four compounds (1m, 1s, 4a, and 6a) exhibited the most potent inhibitory activity compared to that of the reference drug (Zileuton), with IC50 values less than I mu M. Molecular modeling studies for compounds 1a, 3a, 4a, and 6a were also presented. The excellent in vitro activities of this class of compounds may possess potential for the treatment of LT-related diseases. (C) 2007 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.02.038
• 作为产物：
  描述：

  甲醇 、 3-(5-甲氧基-2-甲基-吲哚-3-基)-丙酸 在 硫酸 作用下， 生成 5-methoxy-2-methyl-1H-indole-3-propanoic acid methyl ester
  参考文献：
  名称：

  Indole derivatives as potent inhibitors of 5-lipoxygenase: Design, synthesis, biological evaluation, and molecular modeling

  摘要：

  A series of novel indole derivatives was designed, synthesized and evaluated by cell-based assays for their inhibitory activities against 5-LOX in rat peritoneal leukocytes. Most of them (30 out of 35) showed an inhibitory potency higher than the initial screening hit 1a (IC50 = 74 mu M). Selected compounds for concentration-response studies showed prominent inhibitory activities with IC50 values ranging from 0.74 mu M to 3.17 mu M. Four compounds (1m, 1s, 4a, and 6a) exhibited the most potent inhibitory activity compared to that of the reference drug (Zileuton), with IC50 values less than I mu M. Molecular modeling studies for compounds 1a, 3a, 4a, and 6a were also presented. The excellent in vitro activities of this class of compounds may possess potential for the treatment of LT-related diseases. (C) 2007 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.02.038

文献信息

• 1H-indole-3-acetic acid hydrazide sPLA.sub.2 inhibitors
  申请人：Eli Lilly and Company

  公开号：US05578634A1

  公开（公告）日：1996-11-26

  A class of novel 1H-indole-3-acetic acid hydrazides is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids (e.g., arachidonic acid) for treatment of conditions such as septic shock.

  一类新型的1H-吲哚-3-乙酸肼类化合物被揭示，以及利用这类吲哚化合物抑制sPLA.sub.2介导的脂肪酸（例如花生四烯酸）释放，用于治疗诸如感染性休克等疾病。
• 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
  申请人：ELI LILLY AND COMPANY

  公开号：EP0620214B1

  公开（公告）日：1999-03-03
• US5578634A
  申请人：——

  公开号：US5578634A

  公开（公告）日：1996-11-26